Intelligent design that makes a difference

Bringing safe and efficacious medicinal drugs as soon as possible to patients in need is of utmost importance. Running efficient clinical development programs requires innovative approaches that not only expedite development timelines but also maximize the chance of success. Therefore, assessing the feasiblity of innovative, adaptive clinical trial designs for each drug development program has become a default approach within our clinical team. This work is naturally guided by an experienced statistician. Another major focus point during this process is selection of the right target population, supported by biomarkers where necessary and possible. Identifiying potential risks along with working out a risk mitigation approach form part of our clinical trial design optimization efforts, next to an approach to avoid protocol amendments. All to avoid any unnecessary delays of your clinical development program!

Our track record shows our ability to deliver excellent clinical study designs, protocols and reports, and our capability to function as dedicated liaisons for our clients.

Get in touch
with our Xpert

Wil den Hollander

Managing Consultant, Clinical Development